711 filings
Page 19 of 36
4
c7d9qz
12 Mar 20
KEMPHARM / R. LaDuane Clifton ownership change
4:28pm
4
4ix86kzywkw
10 Mar 20
KEMPHARM / Timothy J. Sangiovanni ownership change
4:34pm
4
onchusq9f biqrbjb
5 Mar 20
KEMPHARM / Travis C Mickle ownership change
4:18pm
8-K
arnxo0b4 yaz4
2 Mar 20
KemPharm Submits KP415 NDA to the FDA for the Treatment of ADHD
4:21pm
8-K
yusjfqeih53n742 hi
28 Feb 20
KemPharm Reports Fourth Quarter and Full-Year 2019 Financial Results
7:34am
SEC STAFF
4oc1g4
28 Feb 20
SEC staff action: Order
12:00am
S-8
asn4g 8wfeh2a
28 Feb 20
Registration of securities for employees
12:00am
424B5
3tw6rcp 0qa5
18 Feb 20
Prospectus supplement for primary offering
7:38am
424B5
do290
18 Feb 20
Prospectus supplement for primary offering
7:01am
424B5
8zcwn9k
18 Feb 20
Prospectus supplement for primary offering
6:54am
8-K
11u41
18 Feb 20
Entry into a Material Definitive Agreement
6:39am
SC 13G/A
c02p3t2xkldld252kqn
14 Feb 20
Beneficial ownership report (amended)
4:55pm
SC 13G/A
77jd0z248owddqhrc8ro
14 Feb 20
Beneficial ownership report (amended)
10:25am
SC 13G/A
ukipy rp8kx0xmhbyny
11 Feb 20
Kempharm, Inc
3:52pm
8-K
wu4lzl1fdpi4m6papqsu
10 Feb 20
Departure of Directors or Certain Officers
5:18pm
4
dudjj 2ns0atn5r
7 Feb 20
KEMPHARM / Sven Guenther ownership change
9:39pm
4
gy498bxp zu
7 Feb 20
KEMPHARM / Travis C Mickle ownership change
9:38pm
4
kd0u 4le5rqr
7 Feb 20
KEMPHARM / Timothy J. Sangiovanni ownership change
9:38pm
4
yj0t0d5j ox8iu8mf
7 Feb 20
KEMPHARM / R. LaDuane Clifton ownership change
9:38pm